Virologic and Serologic Markers of Rapid Progression to AIDS After HIV-1 Seroconversion
- 1 December 1996
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 13 (5), 448-455
- https://doi.org/10.1097/00042560-199612150-00008
Abstract
The association between early virologic and immunologic events after human immunodeficiency virus type 1 (HIV-1) infection and progression of HIV-1 infection to acquired immunodeficiency syndrome (AIDS) was studied among 59 homosexual men with documented time of seroconversion. Epidemiologic factors, such as number of lifetime sexual partners, history of sexually transmitted diseases, and other factors, also were studied. All 17 seroconverters in the cohort who developed AIDS within 3 years (rapid progressors = RPs) were compared with 42 men without AIDS for at least 6 years seroconversion (nonrapid progressors = non-RPs). Plasma levels of HIV-1 RNA, p24 antigen, antibodies to HIV-1 structural genes, beta-2 microglobulin, neopterin, and interferon-alpha were measured at four time points: (a) the last seronegative visit, (b) the first seropositive visit, (c) the visit closest to AIDS (or the corresponding visit for the non-RPs) and (d) 6 years after seroconversion (for non-RPs). Up to seroconversion, the RPs had a significantly higher number of lifetime sexual partners than non-RPs (503 versus 171, respectively). At the first seropositive visit, RPs had significantly higher concentrations of plasma HIV-1 RNA (pKeywords
This publication has 38 references indexed in Scilit:
- Quantitation of HIV-1 RNA in Plasma Predicts Outcome after SeroconversionAnnals of Internal Medicine, 1995
- Long-Term Survivors with HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1995
- Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.The Journal of Experimental Medicine, 1994
- Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.The Journal of Experimental Medicine, 1993
- Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?The Lancet, 1992
- Long-term symptomless HIV-1 infection in recipients of blood products from a single donorThe Lancet, 1992
- CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual.Journal of Clinical Investigation, 1991
- Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous seraAIDS, 1990
- AIDS Two Months After Primary Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1988